Phase II study of pematrexed plus carboplatin in previously untreated non-small cell, non-squamous cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Dec 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 07 Dec 2009 New trial record